Evidence map›Paper›PMID 23578393›Full record

ReviewNeuropharmacology2014

Reward and aversion in a heterogeneous midbrain dopamine system.

Stephan Lammel, Byung Kook Lim, Robert C Malenka

Abstract readReview
In one paragraph

Review in Neuropharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 444 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
444citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

444 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Disinhibition of ventral tegmental area during initial punishment learning causes enduring punishment insensitivity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

384 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stephan LammelNancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA 94305, USA.
Byung Kook Lim
Robert C Malenka

Funding

TRANSGENIC COREP01DA008227 · NIDA · YALE UNIVERSITY · PI NESTLER, ERIC J. · 1993 to 2018
$28.1M
Role of synaptotagmins and neurexin ligands in homeostatic synaptic plasticityP50MH086403 · NIMH · STANFORD UNIVERSITY · PI MALENKA, ROBERT C · 2009 to 2019
$18.4M
Cell type-specific role of Homer proteins in synaptic plasticityR21DA032955 · NIDA · STANFORD UNIVERSITY · PI MALENKA, ROBERT C · 2011 to 2012
$436k
NIDA NIH HHS P01 DA008227NIDA NIH HHS R21 DA032955NIMH NIH HHS P50 MH086403
6 · The paper itself

Abstract

The ventral tegmental area (VTA) is a heterogeneous brain structure that serves a central role in motivation and reward processing. Abnormalities in the function of VTA dopamine (DA) neurons and the targets they influence are implicated in several prominent neuropsychiatric disorders including addiction and depression. Recent studies suggest that the midbrain DA system is composed of anatomically and functionally heterogeneous DA subpopulations with different axonal projections. These findings may explain a number of previously confusing observations that suggested a role for DA in processing both rewarding as well as aversive events. Here we will focus on recent advances in understanding the neural circuits mediating reward and aversion in the VTA and how stress as well as drugs of abuse, in particular cocaine, alter circuit function within a heterogeneous midbrain DA system. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'.

Indexed as

RewardAnimalsDopamineHumansNerve NetVentral Tegmental AreaDopamineAADCamino acid decarboxylaseAMPARATP sensitive potassium channelAversionbasolateral amygdalaBLAcaudal linear nucleuschannelrhodopsin 2ChR2CLiCMD2RDADATdopamineDopaminedopamine D2 receptordopamine transporterfasciculus retroflexusfrGADglutamic acid decarboxylaseIFinterfascicular nucleusinterpeduncular nucleusIPNKATPlateral habenulalateral VTAlaterodorsal tegmentumLDTLHblVTAmammillary bodymedial lemniscusmedial terminal nucleus of the accessory optical tractmedial VTAmedium spiny neuronMesocorticalMesolimbicmlMSNMTmVTANAcNMDARN-methyl-d-aspartatenucleus accumbensparabrachial pigmented nucleusparanigral nucleusPBPPFCPNprefrontal cortexretrorubral fieldRewardRLiRMTgrostral linear nucleus of the rapherostromedial tegmental nucleusRRFSNSNcSNrsubstantia nigrasubstantia nigra pars reticulatasubstantia nirgra pars compactaTHtyrosine hydroxylaseventral tegmental areaVentral tegmental areavesicular glutamate transporter 2vesicular monoamine transporter 2VGluT2VMAT2VTAα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor

Identifiers

PMID23578393
PMCPMC3778102

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.